Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

Be aware: FDA has issued a number of 483s related to the water used in nonsterile compounding. Water for nonsterile compounds needs to be USP-grade purified water. If you use a water purification system to produce “purified water” for your nonsterile compounds, make sure to test the water produced for compliance with the USP Purified Water monograph. This includes testing for Total Organic Carbon (TOC), conductivity, and microbial content. If you are not or cannot test the water to ensure it falls within appropriate parameters, discontinue the use of the water system and buy USP grade purified water instead.